[EN] JAK P13K/mTOR COMBINATION THERAPY<br/>[FR] POLYTHÉRAPIE PAR JAK P13K/MTOR
申请人:NOVARTIS PHARMA AG
公开号:WO2013023119A1
公开(公告)日:2013-02-14
Provided herein is a combination therapy comprising a JAK kinase inhibitor and a dual PBK/mTOR inhibitor, as well as methods of treating various cancers through the use of such a combination therapy.
Valderrama, Jaime A.; Gonzalez, Florencia M., Heterocycles, 1993, vol. 36, # 7, p. 1553 - 1560
作者:Valderrama, Jaime A.、Gonzalez, Florencia M.
DOI:——
日期:——
JAK P13K/mTOR COMBINATION THERAPY
申请人:Novartis Pharma AG
公开号:EP2741747A1
公开(公告)日:2014-06-18
A Convenient Preparation of 7-Bromo-2<i>H</i>-1,4-benzothiazine-3,5,8(4<i>H</i>)-trione and Its Application in the Synthesis of the Conaquinone B Skeleton
作者:Ricardo Tapia、Lorena Villalobos、Cristian Salas
DOI:10.1055/s-2007-990895
日期:2007.12
7-Bromo-2H-1,4-benzothiazine-3,5,8(4H)-trione was synthesized by reaction of 5-bromo-2-nitro-1,4-benzoquinone with methyl thioglycolate followed by reductive cyclization and oxidation. The Diels-Alder reaction of the product quinone with myrcene afforded the expected naphthothiazine.